S 3304 1mg | ≥98%
CSNpharm
S 3304
Search Results
S 3304 50mg | ≥98%
CSNpharm
S 3304
Paquinimod 100mg | ≥98%
CSNpharm
Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.
More Information Supplier PagePaquinimod
Paquinimod 50mg | ≥98%
CSNpharm
Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.
More Information Supplier PagePaquinimod
Paquinimod 5mg | ≥98%
CSNpharm
Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.
More Information Supplier PagePaquinimod
Paquinimod 10mg | ≥98%
CSNpharm
Paquinimod is an inhibitor of S100A9 which can prevent S100A9 from binding to TLR-4. Paquinimod is also known as ABR‑215757.
More Information Supplier PagePaquinimod
ML171 100mg | ≥98%
CSNpharm
ML171 is a novel and selective NOX1 inhibitor with IC50 value of 0.25 μM for blocking NOX1-dependent ROS generation in a HEK293-NOX1 recombinant cell system.
More Information Supplier PageML171
ML171 25mg | ≥98%
CSNpharm
ML171 is a novel and selective NOX1 inhibitor with IC50 value of 0.25 μM for blocking NOX1-dependent ROS generation in a HEK293-NOX1 recombinant cell system.
More Information Supplier PageML171
CB 1954 50mg | ≥98%
CSNpharm
CB 1954 is an anticancer prodrug used in gene therapy research and is activated by NAD(P)H Quinone Oxidoreductase 2.
More Information Supplier PageCB 1954
CB 1954 25mg | ≥98%
CSNpharm
CB 1954 is an anticancer prodrug used in gene therapy research and is activated by NAD(P)H Quinone Oxidoreductase 2.
More Information Supplier PageCB 1954